Lv5
1200 积分 2024-05-02 加入
From Hepatocyte to Cholangiocyte: The Remarkable Potential of Transdifferentiation to Treat Cholestatic Diseases
2个月前
已完结
Selective targeting of endothelial and perivascular angiocrine ROCK2 treats liver fibrosis
2个月前
已完结
A Phase 3 Trial of Seladelpar in Primary Biliary Cholangitis
3个月前
已关闭
PTU-100 Efficacy of obeticholic acid treatment in patients with primary biliary cholangitis with cirrhosis
3个月前
已关闭
A Phase 3 Trial of Seladelpar in Primary Biliary Cholangitis
3个月前
已完结
532: EFFICACY AND SAFETY OF SELADELPAR IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS AND COMPENSATED CIRRHOSIS IN THE PHASE 3 PLACEBO-CONTROLLED RESPONSE TRIAL
3个月前
已关闭
A placebo-controlled trial of primary biliary cirrhosis treatment with colchicine and ursodeoxycholic acid
3个月前
已完结
Proof-of-concept study to evaluate the safety and efficacy of saroglitazar in patients with primary biliary cholangitis
3个月前
已完结
Comparative effectiveness of peroxisome proliferator–activated receptor agonists as second-line therapies for primary biliary cholangitis: A systematic review and network meta-analysis
3个月前
已关闭
Mo1547: COMPARING THE SAFTEY AND EFFICACY OF SECOND LINE THERAPIES FOR PBC WITH OBETHICOLIC ACID: A NETWORK META-ANALYSIS
3个月前
已完结
皖公网安备34019202002308
